Key mechanisms of molecular endotypes in chronic urticaria
Revista Alergia México · 2026
DOI: 10.29262/ram.v73i3.1610 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Revista Alergia México, 2026. Verfasst von Jorge Sánchez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Allergology Group (GACE), Alma Mater Hospital of Antioquia, (Medellín, Colombia). jorgem.sanchez@udea.edu.co. Hauptthemen laut MEDLINE: Chronic Urticaria, Urticaria.
Abstract (Originalsprache)
BACKGROUND: Significant advances in understanding the mechanisms underlying urticaria have been observed over the last 20 years; however, their clinical utility has been little studied. OBJECTIVE: To review current evidence regarding the various mechanisms associated with urticaria and their potential clinical utility for the development of diagnostic and/or prognostic biomarkers. METHODOLOGY: A comprehensive review was conducted of articles related to the endotypes, phenotypes, mechanistic processes, and causality of urticaria. RESULTS: Various mechanisms associated with urticaria have been identified; some (IgE and IgG autoantibodies) are supported by in vitro and in vivo studies demonstrating their coexistence in patients with the disease. Other mechanisms (complement, coagulation pathways), while proposed in several studies, lack sufficient experimental evidence to be established as independent endotypic processes. Currently, knowledge regarding endotypes has not translated into the development of biomarkers available for clinical practice. IgE autoantibodies appear promising for prognostic purposes but are not available in routine practice. CONCLUSION: Current advances have provided insight into the main mechanisms underlying urticaria, and various treatment alternatives useful in daily practice have been developed. However, this knowledge has not yet resulted in new diagnostic or prognostic methods. Further research is needed to enable the prospective validation of biomarkers, methodological standardization, and the development of integrated precision medicine models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Experimental Allergology Group (GACE), Alma Mater Hospital of Antioquia, (Medellín, Colombia). jorgem.sanchez@udea.edu.co.
- Clinical and Experimental Allergology Group (GACE), Alma Mater Hospital of Antioquia, (Medellín, Colombia).
- Núñista Research Group in Medicine (GINUMED), Department of Immunology, Rafael Núñez University Corporation (Cartagena, Colombia).
ORCID-Profile: Jorge Sánchez, Andrés Sánchez
Zitieren
APA
Sánchez, J., Caraballo, A. L., & Sánchez, A. (2026). Key mechanisms of molecular endotypes in chronic urticaria. Revista Alergia México. https://doi.org/10.29262/ram.v73i3.1610
Vancouver
Sánchez J, Caraballo AL, Sánchez A. Key mechanisms of molecular endotypes in chronic urticaria. Revista Alergia México. 2026. doi:10.29262/ram.v73i3.1610
BibTeX
@article{Snchez2026,
author = {Sánchez, Jorge and Caraballo, Ana Lorena and Sánchez, Andrés},
title = {Key mechanisms of molecular endotypes in chronic urticaria},
journal = {Revista Alergia México},
year = {2026},
doi = {10.29262/ram.v73i3.1610}
}
EUVIMED